XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption
Unrestricted stock [Member]
Common Stock [Member]
Common Stock [Member]
Unrestricted stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Unrestricted stock [Member]
Accumulated deficit [Member]
Accumulated deficit [Member]
Cumulative Effect, Period Of Adoption
Balance at Feb. 03, 2018 $ 458,558     $ 554   $ 346,300   $ 111,704  
Balance (ASU 2014-09) at Feb. 03, 2018   $ 486             $ 486
Balance, common stock, shares at Feb. 03, 2018       55,438,089          
Share-based compensation expense 11,807         11,807      
Issuance of unrestricted stock awards     $ 180       $ 180    
Issuance of unrestricted stock awards (in shares)         2,056        
Exercise of options to purchase common stock 4,027     $ 1   4,026      
Exercise of options and warrants to purchase common stock (in shares)       145,157          
Vesting of restricted stock units and performance-based restricted stock units 3     $ 3          
Vesting of restricted stock units and performance-based restricted stock units (in shares)       (305,201)          
Common Shares Withheld (7,990)     $ (1)   (7,989)      
Common shares withheld for taxes (in shares)       113,058          
Repurchase and retirement of common stock 1,987         1,987      
Repurchase and retirement of stock (in shares)       (21,810)          
Issuance of common stock to employees under employee stock purchase plan 365         365      
Issuance of common stock to employees under employee stock purchase plan (in shares)       3,413          
Net income 149,645             149,645  
Balance at Feb. 02, 2019 615,094     $ 557   352,702   261,835  
Balance, common stock, shares at Feb. 02, 2019       55,759,048          
Issuance of unrestricted stock awards 12,136   198     12,136 198    
Issuance of unrestricted stock awards (in shares)         1,634        
Exercise of options to purchase common stock 4,109     $ 2   4,107      
Exercise of options and warrants to purchase common stock (in shares)       141,582          
Vesting of restricted stock units and performance-based restricted stock units 2     $ 2          
Vesting of restricted stock units and performance-based restricted stock units (in shares)       (227,020)          
Common Shares Withheld (10,367)     $ (1)   (10,366)      
Common shares withheld for taxes (in shares)       83,121          
Repurchase and retirement of common stock 36,885     $ (3)   36,882      
Repurchase and retirement of stock (in shares)       (337,552)          
Issuance of common stock to employees under employee stock purchase plan 435         435      
Issuance of common stock to employees under employee stock purchase plan (in shares)       3,456          
Net income 175,056             175,056  
Balance at Feb. 01, 2020 $ 759,778     $ 557   322,330   436,891  
Balance, common stock, shares at Feb. 01, 2020 55,712,067     55,712,067          
Issuance of unrestricted stock awards $ 9,294   $ 208     9,294 $ 208    
Exercise of options to purchase common stock 5,346     $ 2   5,344      
Exercise of options and warrants to purchase common stock (in shares)       176,846          
Vesting of restricted stock units and performance-based restricted stock units 2     $ 2          
Vesting of restricted stock units and performance-based restricted stock units (in shares)       (230,002) (1,518)        
Common Shares Withheld (3,917)     $ (1)   (3,916)      
Common shares withheld for taxes (in shares)       51,734          
Repurchase and retirement of common stock 12,663     $ (1)   12,662      
Repurchase and retirement of stock (in shares)       (137,023)          
Issuance of common stock to employees under employee stock purchase plan 477         477      
Issuance of common stock to employees under employee stock purchase plan (in shares)       3,561          
Net income 123,361                
Balance at Jan. 30, 2021 $ 881,886     $ 559   $ 321,075   $ 560,252  
Balance, common stock, shares at Jan. 30, 2021 55,935,237     55,935,237